Form 8-K - Current report:
SEC Accession No. 0001564590-18-014932
Filing Date
2018-06-01
Accepted
2018-06-01 16:50:00
Documents
4
Period of Report
2018-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ANNUAL SHAREHOLDERS MEETING dvax-8k_20180531.htm 8-K 60797
2 EX-10.1 dvax-ex101_6.htm EX-10.1 218542
3 EX-10.2 dvax-ex102_7.htm EX-10.2 61139
4 EX-10.3 dvax-ex103_8.htm EX-10.3 69408
  Complete submission text file 0001564590-18-014932.txt   411191
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 18875719
SIC: 2834 Pharmaceutical Preparations